Factor | Total number (n) | Recurrence number (n) | Recurrence rate (%) | Log-rank test (P value) |
---|---|---|---|---|
Age (years) | Â | Â | Â | Â |
   ≤ 40 | 57 | 1 | 1.754 | 0.179 |
   > 40 | 367 | 22 | 5.995 | |
Pathological type | Â | Â | Â | Â |
  Squamous carcinoma | 328 | 20 | 6.098 | 0.275 |
  Adenocarcinoma and others | 96 | 3 | 3.125 | |
Histological grade | Â | Â | Â | Â |
  Poorly differentiated | 246 | 21 | 8.537 | 0.000 |
  Moderately or highly differentiated | 178 | 2 | 1.124 | |
Clinical stage | Â | Â | Â | Â |
   ≤ IB | 224 | 2 | 0.893 | 0.000 |
   > IB | 200 | 21 | 10.500 | |
Adjuvant therapy | Â | Â | Â | Â |
  With | 139 | 8 | 5.755 | 0.597 |
  Without | 143 | 10 | 6.993 | |
Pelvic lymph node | Â | Â | Â | Â |
  Positive | 106 | 17 | 16.038 | 0.000 |
  Negative | 318 | 6 | 1.887 | |
Postoperative radiotherapy | Â | Â | Â | Â |
  With | 179 | 8 | 4.469 | 0.000 |
  Without | 77 | 8 | 15.584 | |
Postoperative chemotherapy | Â | Â | Â | Â |
  With | 182 | 5 | 2.747 | 0.007 |
  Without | 64 | 7 | 10.938 |  |